Refractory Myelodysplastic Syndromes
3 clinical trials · Condition
◉ Watch Refractory Myelodysplastic Syndromes
| Record | Firm | Date |
|---|---|---|
| FHD-286 as Monotherapy or Combination Therapy in Subjects With Advanced Hematologic Malignancies (NCT04891757) | Foghorn Therapeutics Inc. | 2021-06-14 |
| NKX101, Intravenous Allogeneic CAR NK Cells, in Adults With AML or MDS (NCT04623944) | Nkarta, Inc. | 2020-09-21 |
Track Refractory Myelodysplastic Syndromes automatically
Every clearance here is in the API, with alerts when new ones post.